From the record

Roche's divarasib shows superior efficacy compared to Amgen's and Bristol Myers Squibb's drugs in a clinical trial for KRAS G12C-mutated lung cancer.

Items older than 7 days — their verdicts, sources and coverage history — are part of the Azimuth Daily record and available to signed-in readers.